Fibrinogen E-fragment Inhibits the Migration and Tubule Formation of Human Dermal Microvascular Endothelial Cells in Vitro
Overview
Authors
Affiliations
Angiogenesis, the development of new blood vessels from an existing vascular bed, is essential for the growth and spread of malignant tumors. Several endogenous angiogenesis inhibitors have been discovered and shown to suppress endothelial cell function in vitro and tumor growth in vivo. Several of these are proteolytic fragments of larger, endogenous proteins. Here we show that a Mr 50,000 polypeptide derived from the plasmin cleavage of fibrinogen, fibrinogen E-fragment, inhibits endothelial cell migration and tubule formation induced by both proangiogenic growth factors, vascular endothelial growth factor and basic fibroblast growth factor, in vitro.
Ponsen A, Proust R, Soave S, Mercier-Nome F, Garcin I, Combettes L Bioact Mater. 2022; 18:368-382.
PMID: 35415309 PMC: 8965972. DOI: 10.1016/j.bioactmat.2022.01.049.
Ferreira A, Cristofaro B, Menezes M, Oliveira A, Tashima A, de Melo R Oncotarget. 2021; 11(51):4770-4787.
PMID: 33473260 PMC: 7771711. DOI: 10.18632/oncotarget.27839.
Customizable 3D-Printed (Co-)Cultivation Systems for In Vitro Study of Angiogenesis.
Siller I, Epping N, Lavrentieva A, Scheper T, Bahnemann J Materials (Basel). 2020; 13(19).
PMID: 32992945 PMC: 7579111. DOI: 10.3390/ma13194290.
Fibrinogen-derived fibrinostatin inhibits tumor growth through anti-angiogenesis.
Zhao C, Su Y, Zhang J, Feng Q, Qu L, Wang L Cancer Sci. 2015; 106(11):1596-606.
PMID: 26300396 PMC: 4714678. DOI: 10.1111/cas.12797.
Fu G, Hu M, Chu L, Zhang M Int J Endocrinol. 2015; 2015:758402.
PMID: 26089891 PMC: 4451558. DOI: 10.1155/2015/758402.